Lowering insulin prices isn’t the (only) answer to helping patients with diabetes
It is time to shift the conversation, incentives, and policy solutions to help people improve their health and get off of medications—not just make them […]
obesity
A Free-for-All From Readers and Tweeters, From Medical Debt to Homelessness
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. It […]
How AI Can Accurately Detect Diabetes Through Retinal Images
Recent advancements in AI have demonstrated that AI can accurately detect diabetes through the analysis of retinal images that retina experts would consider healthy. To […]
Are Plan B and Body Weight Interconnected?
Researchers have looked into why and how weight influences emergency contraception but have come up against several unknowns. Here’s what we know.
Are Plan B and Body Weight Interconnected?
Researchers have looked into why and how weight influences emergency contraception but have come up against several unknowns. Here’s what we know.
Are Plan B and Body Weight Interconnected?
Researchers have looked into why and how weight influences emergency contraception but have come up against several unknowns. Here’s what we know.
Does Plan B Have a Weight Limit?
Researchers have looked into why and how weight influences emergency contraception but have come up against several unknowns. Here’s what we know.
Readers and Tweeters Weigh In on America’s Medical Debt, Obesity Epidemic, and Opioid Battles
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. So, […]
New Weight Loss Treatment Is Marked by Heavy Marketing and Modest Results
First came the “edible billboard,” which appeared last year during the holidays in New York’s East Village loaded with cake treats. Then, in late January, […]
The Doctor Prescribed an Obesity Drug. Her Insurer Called It ‘Vanity.’
Many insurance companies refuse to cover new weight loss drugs that their doctors deem medically necessary.
Phenomix Sciences Launches Obesity Biobanking Registry Studying Personalized Treatment Options Based on Genetics
What You Should Know: – Biotech company Phenomix Sciences launches its biobanking registry, marking the first obesity registry to study the impact of personalized treatment based on phenotyping. The […]
Nueva meta de las escuelas de medicina: médicos que no discriminen a pacientes obesos
Cuando Melissa Boughton se quejó con su gineco-obstetra de un dolor pélvico, la doctora respondió preguntándole sobre su dieta y sus hábitos de ejercicio. En […]
To Shed Bias, Doctors Get Schooled to Look Beyond Obesity
When Melissa Boughton complained to her OB-GYN about dull pelvic pain, the doctor responded by asking about her diet and exercise habits. The question seemed […]
Bison Pastrami, Anyone? Preschool Assistant Makes Sure Kids Get to Know Indigenous Foods
MINNEAPOLIS — Bison pastrami is not typical school lunch fare, but it’s a crowd favorite at a preschool in Minneapolis. Fawn Youngbear-Tibbetts — the seemingly […]
Delivering Patient-Centered Care Means Decluttering the Digital Health Landscape
Simon Mathews, MD, Chief Medical Officer, Pager Digital health companies (DHCs) and their solutions continue to grow at a rapid pace. This is in part […]
Raising Clinical Outcomes and Engagement Through Healthcare Equity: What Health Plans Need to Know
Anne Davis, VP of Government Markets & Strategy at Wellth Structural racism and poverty are correlated with a higher incidence of obesity among Black Americans […]
Patients Taking Experimental Obesity Drug Lost More Than 50 Pounds, Maker Claims
The data have not yet been peer reviewed or published. But experts said the drug may give people with obesity an alternative to bariatric surgery.
Patients Taking Experimental Obesity Drug Lost More Than 50 Pounds, Maker Claims
The data have not yet been peer reviewed or published. But experts said the drug may give people with obesity an alternative to bariatric surgery.
Patients Taking Experimental Obesity Drug Lost More Than 50 Pounds, Maker Claims
The data have not yet been peer reviewed or published. But experts said the drug may give people with obesity an alternative to bariatric surgery.
Patients Taking Experimental Obesity Drug Lost More Than 50 Pounds, Maker Claims
The data have not yet been peer reviewed or published. But experts said the drug may give people with obesity an alternative to bariatric surgery.
Patients Taking Experimental Obesity Drug Lost More Than 50 Pounds, Maker Claims
The data have not yet been peer reviewed or published. But experts said the drug may give people with obesity an alternative to bariatric surgery.
Lilly fires a broadside at Novo Nordisk’s obesity ambitions
Denmark’s Novo Nordisk has been almost single-handedly rebuilding the market for drugs to treat obesity over the last few years with its GLP-1 agonist drugs […]
Obesity is a disease—and it’s treatable
Obesity is a disease, and America’s healthcare providers and hospital systems must be part of changing how we treat it. That means many of us […]
Novo Nordisk eyes obesity sales of $3.7bn in 2025 thanks to Wegovy
Novo Nordisk’s rollout of obesity therapy Wegovy has been beset by production problems, but the company says these are being resolved and it now anticipates […]
Obesity Across America
The Urban Institute has an interesting report titled Obesity Across America. Being overweight (BMS>25), obese (BMI>30) or severely obese (BMI>40) is very common in the […]
CVS Health Releases Drug Trend Report
What You Should Know: – CVS Health released their Drug Trend Report, examining the drivers of overall and specialty drug trend through the first three quarters of 2021. Data were calculated on a […]
Novo Nordisk gets NICE okay for obesity drug Wegovy
Novo Nordisk’s new obesity therapy Wegovy has been recommended for routine NHS use by UK cost-effectiveness watchdog NICE, but in a narrower group of patients […]
Preventing Alzheimer’s Disease with Diet
What evidence is there that our meat-sweet diets play a cause-and-effect role in dementia? What is behind the dramatic increase in dementia in Japan over […]
Novo Nordisk moves to strengthen obesity efforts
After securing FDA approval for Wegovy last year, Novo Nordisk is strengthening its position in the obesity space through a collaboration with EraCal Therapeutics. Under […]
Apple Peels Put to the Test for Chronic Joint Pain
Are the health benefits associated with apple consumption simply due to other healthy behaviors among apple-eaters? Regular apple intake is associated with all sorts of […]
Coronavirus Briefing: What Happened Today
Pfizer and BioNTech say booster shots offer strong protection against Omicron.
Coronavirus Briefing: What Happened Today
Pfizer and BioNTech say booster shots offer strong protection against Omicron.
Coronavirus Briefing: What Happened Today
Pfizer and BioNTech say booster shots offer strong protection against Omicron.
Novo Nordisk’s Wegovy (semaglutide) Receives CHMP’s Recommendation for Approval to Treat Obesity
Shots: The EMA’s CHMP has adopted a positive opinion recommending the marketing authorization for Wegovy in adults with obesity in chronic weight management in adults […]
Novo Nordisk nears EU approval of obesity drug Wegovy
Danish drugmaker Novo Nordisk is hoping to launch its once-weekly injectable treatment for obesity, Wegovy, in the EU next year after getting a green light […]
Does Coconut Oil Help with Abdominal Fat?
What does a review of the evidence on the effects of coconut oil on weight loss and belly fat find? I begin my video Flashback Friday: Coconut Oil and Abdominal Fat with a popular infographic that […]
Versanis Bio unveils $70M and a Novartis drug ready for Phase 2 test in obesity
Novartis was unsuccessful developing bimagrumab as a treatment for a rare muscle disorder, but additional tests showed encouraging results in fat reduction. Startup Versanis Bio […]
Diabetes Drug’s New Weight Loss Formula Fuels Cost-Benefit Debate
The long list of side effects that follow ads for the newer expensive drugs to treat Type 2 diabetes sometimes include an unusual warning: They […]
Regeneron, AZ team up on drugs for obesity “superpower” gene
AstraZeneca has formed a partnership with Regeneron to investigate the potential of treating obesity using drugs directed at GPR75, a protective gene identified by scientists […]
AstraZeneca and Regeneron Collaborate to Research, Develop and Commercialize Therapies for Obesity
Shots: The companies collaborated to research, develop & commercialize small molecules directed against the GPR75 target with the potential to treat obesity and related co-morbidities […]
America’s obesity epidemic requires action, not posturing
Pinterest’s move to outright ban all ads referring to weight loss — regardless of quality of information — is woefully misguided, writes a former Pinterest […]
Fasting for Weight Loss Infographic
Fasting has been branded the “next big weight loss fad,” and about one in seven Americans report using some sort of fasting as a means for […]
Innovent Reports First Patient Dosing in P-II Clinical Trial for the Treatment of Obesity in China
Shots: The first patient has been dosed in a P-II clinical trial evaluating the efficacy and safety of IBI362 (GLP-1R and GCGR dual agonist) in […]
Novo Nordisk’s Wegovy (semaglutide, 2.4mg) Receives the US FDA’s Approval for Weight Management in Adults with Obesity
Shots: The approval is based on the results from the P-IIIa STEP clinical trial program evaluating Wegovy (2.4mg injection, qw) in ~4,500 adults with obesity […]
FDA ends 7-year obesity drug drought, clearing Novo Nordisk’s Wegovy
Novo Nordisk is celebrating the FDA approval of its GLP-1 agonist semaglutide as a treatment for obesity, which it believes has the potential to redefine […]
FDA ends 7-year obesity drug drought, clearing Novo Nordisk’s Wegovy
Novo Nordisk is celebrating the FDA approval of its GLP-1 agonist semaglutide as a treatment for obesity, which it believes has the potential to redefine […]
Nuevos fármacos podrían tratar la obesidad, ¿podrán acabar con el estigma?
La esperanza es que los nuevos tratamientos animen a la gente a considerar la obesidad como una condición crónica, como la hipertensión o la diabetes.
Nuevos fármacos podrían tratar la obesidad, ¿podrán acabar con el estigma?
La esperanza es que los nuevos tratamientos animen a la gente a considerar la obesidad como una condición crónica, como la hipertensión o la diabetes.
Nuevos fármacos podrían tratar la obesidad, ¿podrán acabar con el estigma?
La esperanza es que los nuevos tratamientos animen a la gente a considerar la obesidad como una condición crónica, como la hipertensión o la diabetes.
Nuevos fármacos podrían tratar la obesidad, ¿podrán acabar con el estigma?
La esperanza es que los nuevos tratamientos animen a la gente a considerar la obesidad como una condición crónica, como la hipertensión o la diabetes.
Weekly Health Quiz: Weight-Loss Drugs, Psychedelics and Friends
Test your knowledge of this week’s health news.
Weekly Health Quiz: Weight-Loss Drugs, Psychedelics and Friends
Test your knowledge of this week’s health news.
Novo Nordisk Reports Results of Semaglutide from P-IIIa STEP 1 Trial in Patients with Obesity
Shots: The company reported the results from the P-IIIa STEP 1 trial of the STEP programme assessing semaglutide (2.4 mg, SC, qw) vs PBO in […]
Weekly Health Quiz: Weight-Loss Drugs, Psychedelics and Friends
Test your knowledge of this week’s health news.
New Drugs Could Help Treat Obesity. Could They End the Stigma, Too?
The hope is that new treatments will encourage people to think of obesity as a chronic disease, like high blood pressure or diabetes.
New Drugs Could Help Treat Obesity. Could They End the Stigma, Too?
The hope is that new treatments will encourage people to think of obesity as a chronic disease, like high blood pressure or diabetes.
New Drugs Could Help Treat Obesity. Could They End the Stigma, Too?
The hope is that new treatments will encourage people to think of obesity as a chronic disease, like high blood pressure or diabetes.
Novo Nordisk to Initiate P-IIIa Study for Oral Semaglutide to Treat Obesity
Shots: The company plan to initiate a pivotal P-IIIa program to assess the efficacy and safety of oral semaglutide (50mg) vs PBO in ~1000 people […]
Novo Nordisk Presents Results of Semaglutide in P-IIIa STEP 4 Trial to Treat Obesity at ENDO 2021
Shots: The P-IIIa STEP 4 trial involves assessing the safety and efficacy of Semaglutide (2.4 mg, SC, qw) vs PBO in adults with obesity for […]
How NLP Can Uncover Social Determinants of Heart Disease
David Talby, CTO, John Snow Labs Heart disease is the leading cause of death for people of most racial and ethnic groups in the United […]
Glooko Raises $30M to Expand Digital Diabetes Management Platform
What You Should Know: – Glooko, a Palo Alto, CA-based provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, today […]
Are Lectins in Food Good or Bad for You?
Might lectins help explain why those who eat more beans and whole grains have less cancer? Lectins are to blame for the great “white kidney […]
Innovative, Non-Invasive Technologies Advanced Earlier Detection & Monitoring of Liver Disease
Jon Gingrich, CEO, Echosens North America Leveraging technological advances to facilitate new ways of engaging patients and integrating non-invasive technology into a liver disease program […]
Pfizer vaccine may be less effective in people with obesity, says study
Healthcare workers with obesity found to produce only about half the antibodies healthy people do Coronavirus – latest updates See all our coronavirus coverage The […]
Novo Nordisk’s semaglutide effective against obesity in new trial
Novo Nordisk’s hopes of getting semaglutide approved for obesity management may have received a boost, with a new, large trial showing the drug was able […]
Semaglutide Brings Significant Weight Loss in Obese Patients
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
Semaglutide Brings Significant Weight Loss in Obese Patients
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
Semaglutide Brings Significant Weight Loss in Obese Patients
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
Semaglutide Brings Significant Weight Loss in Obese Patients
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
Semaglutide Brings Significant Weight Loss in Obese Patients
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
‘A Game Changer’: Drug Brings Significant Weight Loss in Obese Patients
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.
DarioHealth Acquires Musculoskeletal Solution Upright for $31M
What You Should Know: – DarioHealth, a Livongo competitor acquires musculoskeletal startup Upright for $31 million to expand their chronic condition management capabilities focused on […]
Do the Pros of Brown Rice Outweigh the Cons of Arsenic?
Are there unique benefits to brown rice that would justify keeping it in our diet despite the arsenic content? For years, warnings had been given […]
The Obesity Pandemic: What can we do about it?
Obesity today is a global crisis; the number of cases is on a continuous rise. As per the WHO, “during the years 1975 to 2016, […]
Humana Taps Vida Health to Power Virtual Diabetes Management for Kentucky’s Medicaid Population
What You Should Know: – Humana Healthy Horizons™ in Kentucky announced it has selected Vida Health’s virtual diabetes management program to serve Kentucky’s Medicaid population. – […]
Digital Diabetes Market to Reach $1.5B by 2024, Research Finds
What You Should Know: – The digital diabetes market is on track to reach $1.5 billion dollars by 2024, according to a new report by Research2Guidance. […]
How Care Coordination Technology Addresses Social Isolation in Seniors
Jenifer Leaf Jaeger, MD, MPH, Senior Medical Director, HealthEC Senior isolation is a health risk that affects at least a quarter of seniors over 65. […]
Price cut leads NICE to back Novo Nordisk’s obesity drug Saxenda
Novo Nordisk’s Saxenda has been recommended by NICE as a treatment for obesity, ending a 10-year drought in new drug therapies for weight management. The […]
What White Blood Cell Count Should We Shoot for?
At the start of my video What Does a Low White Blood Cell Count Mean?, you can see what it looks like when you take […]
No Purveyor of Unhealthy Products Wants the Public to Know the Truth
In 2011, Denmark introduced the world’s first tax on saturated fat. “After only 15 months, however, the fat tax was abolished,” due to massive pressure […]
Rural Hospital Execs Can Beat COVID-19 By Shifting From Reactive to Proactive Care
Eric Tran, Tulane School of Medicine Donald Voltz, MD, Aultman Hospital The COVID-19 virus is ravaging the planet at a scale not seen since the […]
How to Treat Polycystic Ovary Syndrome (PCOS) with Diet
Given the role that oxidant free radicals are thought to play in aging and disease, one reason fruits and vegetables may be so good for […]
Virta Expands Offerings to Treat New Group of Chronic Illnesses
What You Should Know: – Virta is expanding its suite of treatment options to include prediabetes reversal, obesity reversal, and type 2 diabetes management. – […]
Accounting for the Social Determinants of Health During the COVID-19 Pandemic
Andy Aroditis, CEO, NextGate The COVID-19 pandemic is not just a medical crisis. Since the highly contagious disease hit American shores in early 2020, the […]
4 Ways Businesses Will Adapt Their Healthcare Landscape
Dr. Donald Brown, CEO and founder of LifeOmic The coronavirus pandemic has affected every aspect of our lives, from how we work to how we […]
FDA, Syapse Expand Research to Generate Real-World Data Related to COVID-19 and Cancer
What You Should Know: The FDA and Syapse announce research collaboration expansion to address urgent public health challenges including supporting FDA’s goal of rapid understanding […]
Epidemia de obesidad en los Estados Unidos amenaza la eficacia de una vacuna contra COVID
Para un mundo paralizado por el coronavirus, la salvación depende de una vacuna. Pero en los Estados Unidos, en donde al menos 4,6 millones de […]
America’s Obesity Epidemic Threatens Effectiveness of Any COVID Vaccine
For a world crippled by the coronavirus, salvation hinges on a vaccine. But in the United States, where at least 4.6 million people have been […]
Merck & Co to repurpose failed obesity drug for NASH
Merck & Co is to pay $10 million to Hanmi to repurpose an obesity drug discarded by Johnson & Johnson, into a therapy for the […]
The Crowding Out Strategy to Eating Healthier
It may be more expedient politically to promote an increase in consumption of healthy items rather than a decrease in consumption of unhealthy items, but […]
How to Foster a Healthy Gut Flora
What’s more important: probiotics or prebiotics? And where can we best get them? “Virtually every day we are all confronted with the activity of our […]
There are many reasons why obesity puts people at risk of becoming critically ill from COVID-19
The post There are many reasons why obesity puts people at risk of becoming critically ill from COVID-19 appeared first on Healthy Debate.
